[Remote] Anatomic Pathologist at Natera

United States

Natera Logo
Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Healthcare, DiagnosticsIndustries

Requirements

Candidates must possess an MD/DO degree and be ABP board-certified/eligible in AP/CP and Molecular Genetic Pathology. A qualified and unrestricted Medical License to practice in California is required, with current California Medical License holders being preferred.

Responsibilities

The Pathologist will provide clinical oversight for laboratory testing, ensuring accuracy and compliance with regulatory standards. Responsibilities include reviewing patient specimens and clinical notes, performing tumor analysis for molecular testing, and approving oncology testing reports. The role involves overseeing the review of genetic and CNV variant data, interpreting NGS and microarray results, and providing clinical support. This position also entails setting and maintaining laboratory testing standards, analyzing lab data for publications, serving as a Clinical Consultant for assay utility and test interpretation, and acting as a Technical Supervisor responsible for method selection, verification, proficiency testing, quality assessment, and personnel competency. Additionally, the Pathologist will manage a team, review assigned work, and mentor personnel.

Skills

Anatomic Pathology
Laboratory Testing
Regulatory Standards
Histology
FFPE Tissue Processing
Slide Staining
NGS Platforms
SNP Array Analysis
Genetic Variant Data Interpretation
Medical Literature
Variant Databases
Clinical Consultation
Assay Utility
Test Appropriateness
Scientific Publications

Natera

Genetic testing and diagnostics solutions provider

About Natera

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera stands out by offering specialized tests like the Signatera ctDNA test and Panorama NIPT, along with genetic counseling services. The company's goal is to improve patient care and health outcomes through accurate genetic testing.

Austin, TexasHeadquarters
2004Year Founded
$149.9MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
1,001-5,000Employees

Benefits

Flexible medical plans
Investment options
Time off
Workplace perks

Risks

Hindenburg report accuses Natera of deceptive sales practices, risking legal challenges.
New Prospera Heart features may face slow adoption by healthcare providers.
Fetal RhD NIPT demand may drop post-RhIg shortage, affecting future sales.

Differentiation

Natera's Signatera test offers personalized ctDNA analysis for cancer patients.
Prospera Heart test uses unique Donor Quantity Score for transplant rejection detection.
Panorama NIPT test is a leader in non-invasive prenatal testing with 2 million tests.

Upsides

Increased adoption of liquid biopsy techniques boosts demand for Natera's cfDNA tests.
AI integration enhances accuracy and speed of Natera's cfDNA analysis.
Growing personalized medicine trend aligns with Natera's customized genetic tests.

Land your dream remote job 3x faster with AI